Related Experiment Video

Updated: May 23, 2026

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Preparation of Polyclonal Antibodies from Plasma or Serum Using the Gradiflow BF400 Instrument

Vicki L Locke, Theresa M Thomas

    CSH Protocols
    |April 10, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    Laboratory Scale Production and Purification of a Therapeutic Antibody
    09:54

    Laboratory Scale Production and Purification of a Therapeutic Antibody

    Published on: January 24, 2017

    Related Experiment Videos

    Last Updated: May 23, 2026

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
    13:14

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

    Published on: February 6, 2018

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    Laboratory Scale Production and Purification of a Therapeutic Antibody
    09:54

    Laboratory Scale Production and Purification of a Therapeutic Antibody

    Published on: January 24, 2017

    Related Concept Videos

    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...

    Articles linked to this work by shared authors, journal, and citation graph.

    Two-dimensional liquid chromatography/tandem mass spectrometry analysis of Gradiflow fractionated native human plasma.

    Proteomics·2005

    Cellular models of drug- and radiation-resistant small cell lung cancer.

    Anticancer research·2004

    Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.

    Protein expression and purification·2003

    Modulation of drug and radiation resistance in small cell lung cancer cells by paclitaxel.

    Anti-cancer drugs·2003

    The purification of IgY from chicken egg yolk by preparative electrophoresis.

    Protein expression and purification·2003

    Depletion of the highly abundant protein albumin from human plasma using the Gradiflow.

    Proteomics·2003

    Identification of positive GATEWAY expression clones when both the pENTRY and pDEST vectors contain the same marker for bacterial selection.

    CSH protocols·2012

    Imaging protein interactions by FRET microscopy: cell preparation for FRET analysis.

    CSH protocols·2012

    Imaging protein interactions by FRET microscopy: labeling proteins with fluorescent dyes.

    CSH protocols·2012

    Bradford assay.

    CSH protocols·2012

    Detection of ubiquitylated proteins in mammalian cells.

    CSH protocols·2012

    Imaging of organelle membrane systems and membrane traffic in living cells.

    CSH protocols·2012

    Mechanisms of antibody-mediated enhancement of immune responses.

    The Journal of experimental medicine·2026

    A predictive multiscale framework for post-translational modification-dependent peptide-MHC class I binding.

    Physical chemistry chemical physics : PCCP·2026

    Persistently Elevated Serum IgM: A Diagnostic Red Flag for Primary Immunodeficiencies: A Case-Based Review and Clinical Approach.

    Endocrine, metabolic & immune disorders drug targets·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us